AU1729900A - The cxc chemokine h174 and methods for preventing damage to the nervous system - Google Patents
The cxc chemokine h174 and methods for preventing damage to the nervous systemInfo
- Publication number
- AU1729900A AU1729900A AU17299/00A AU1729900A AU1729900A AU 1729900 A AU1729900 A AU 1729900A AU 17299/00 A AU17299/00 A AU 17299/00A AU 1729900 A AU1729900 A AU 1729900A AU 1729900 A AU1729900 A AU 1729900A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- nervous system
- preventing damage
- cxc chemokine
- cxc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19309298A | 1998-11-16 | 1998-11-16 | |
US09193092 | 1998-11-16 | ||
PCT/US1999/027199 WO2000029439A1 (en) | 1998-11-16 | 1999-11-16 | The cxc chemokine h174 and methods for preventing damage to the nervous system |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1729900A true AU1729900A (en) | 2000-06-05 |
Family
ID=22712256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17299/00A Abandoned AU1729900A (en) | 1998-11-16 | 1999-11-16 | The cxc chemokine h174 and methods for preventing damage to the nervous system |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1133521A1 (en) |
AU (1) | AU1729900A (en) |
CA (1) | CA2351146A1 (en) |
WO (1) | WO2000029439A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE054034T2 (en) | 2014-03-13 | 2021-08-30 | Univ Basel | Carbohydrate ligands that bind to igm antibodies against myelin-associated glycoprotein |
JP6849667B2 (en) | 2015-09-16 | 2021-03-24 | ウニヴェルズィテート バーゼル | Carbohydrate ligand that binds to antibodies against glycosphingolipid sugar chain epitopes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739103A (en) * | 1993-11-12 | 1998-04-14 | Dana-Farber Cancer Institute | Chemokine N-terminal deletion mutations |
WO1998011138A1 (en) * | 1996-09-12 | 1998-03-19 | Human Genome Sciences, Inc. | Chemokine alpha-4 |
EP0887409A1 (en) * | 1997-06-26 | 1998-12-30 | Ernst Werner | Chemokine MIG-beta: cDNA fragment, protein, expression vector, transformed cell, diagnosis methods and pharmaceutical composition |
-
1999
- 1999-11-16 EP EP99960408A patent/EP1133521A1/en not_active Withdrawn
- 1999-11-16 AU AU17299/00A patent/AU1729900A/en not_active Abandoned
- 1999-11-16 WO PCT/US1999/027199 patent/WO2000029439A1/en not_active Application Discontinuation
- 1999-11-16 CA CA002351146A patent/CA2351146A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2351146A1 (en) | 2000-05-25 |
WO2000029439A1 (en) | 2000-05-25 |
WO2000029439A9 (en) | 2000-11-09 |
EP1133521A1 (en) | 2001-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU693738B2 (en) | Photovoltaic device and process for the production thereof | |
AU4336500A (en) | Methods and systems for providing group calls with reduced setup times | |
AU3254595A (en) | 2-phenyl indoles as anti-oestrogen drugs | |
AU4303997A (en) | Protective structure | |
SG55362A1 (en) | Earphone | |
AU3604897A (en) | Photovoltaic device | |
EP1093011A3 (en) | Device and system for waveform shaping | |
PL328774A1 (en) | Crosslinkable protective colloids | |
AU1483295A (en) | Benzimidazoles | |
IL109963A0 (en) | E2-f1 enzyme and methods for the isolation, purification and use thereof | |
EP0680079A3 (en) | Thin-film structure tapered feature. | |
AU4251197A (en) | Therapeutic chemokine antagonists | |
HU9701949D0 (en) | Clamping structure | |
AU3068700A (en) | Transportation protection device and method for producing the same | |
PL354994A1 (en) | Bio-supportive matrices, methods of making and using the same | |
ZA953752B (en) | Benzimidazoles and imidazopyridines as central nervous system agents | |
EP1218915A4 (en) | Systems and methods for high performance scanning | |
AU1729900A (en) | The cxc chemokine h174 and methods for preventing damage to the nervous system | |
TW316020U (en) | Concentrator with voice function | |
AU5276699A (en) | Clamping nut | |
AU3062699A (en) | Crack injector system | |
AU2272401A (en) | Nut and nut holder | |
AU3087695A (en) | Construction system to be used in semi-permanent construction | |
AU2002301408A1 (en) | Regeneration system for grape and uses thereof | |
HUP9903711A3 (en) | Chemokine beta-15 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |